VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
FBIO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
FBIOFortress Biotech, Inc.
$2.99$115M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksFBIOQuarterly Financials

Fortress Biotech, Inc. (FBIO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Fortress Biotech, Inc. (FBIO) quarterly income statement — complete revenue, gross profit & net income history

FBIO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue16.04M16.08M17.63M16.41M13.14M15.12M14.63M14.9M13.03M19.95M34.75M17.39M12.43M16.4M16.53M18.89M23.93M18.28M21.09M17.84M
Revenue Growth %22.06%6.34%20.52%10.18%0.84%-24.2%-57.9%-14.32%4.84%21.59%110.26%-7.94%-48.05%-10.24%-21.61%5.85%106.48%32.93%122.53%88.68%
Cost of Goods Sold7.34M5.44M5.75M4.94M4.79M5.8M5.29M6.54M6M6.01M6.43M7.77M6.45M8.54M7.22M7.63M8.2M10.29M11.17M7.48M
COGS % of Revenue45.79%33.83%32.64%30.09%36.46%38.39%36.13%43.91%46.06%30.16%18.5%44.67%51.89%52.07%43.69%40.42%34.29%56.28%52.96%41.94%
Gross Profit8.69M10.64M11.88M11.47M8.35M9.31M9.34M8.36M7.03M13.93M28.32M9.62M5.98M7.86M9.31M11.25M15.72M7.99M9.92M10.36M
Gross Margin %54.21%66.17%67.36%69.91%63.54%61.61%63.87%56.09%53.94%69.84%81.5%55.33%48.11%47.93%56.31%59.58%65.71%43.72%47.04%58.06%
Gross Profit Growth %4.13%14.21%27.1%37.33%18.8%-33.13%-67.01%-13.14%17.53%77.17%204.32%-14.52%-61.96%-1.6%-6.16%8.63%104.74%-9.85%62.7%63.57%
Operating Expenses16.43M15.43M18.69M47.95M30.67M36.66M31.44M36.14M43.59M33.55M42.08M59.72M64.85M62.5M60.04M62.18M62.99M69.99M59.84M53.22M
OpEx % of Revenue102.46%95.95%105.99%292.13%233.4%242.46%214.91%242.64%334.57%168.18%121.09%343.52%521.74%380.99%363.27%329.23%263.29%382.97%283.81%298.25%
Selling, General & Admin15.89M14.73M17.41M38.76M25.66M26.72M21.99M20.82M17.94M22.61M21.73M24.44M25.34M27.38M30.14M29.05M26.27M26.94M22.22M19.38M
SG&A % of Revenue99.1%91.61%98.77%236.14%195.32%176.72%150.34%139.79%137.69%113.37%62.54%140.57%203.89%166.89%182.35%153.81%109.8%147.4%105.39%108.63%
Research & Development540K-367K208K8.13M3.94M9.94M9.45M12.67M24.84M14.08M20.35M32.14M39.51M35.12M29.9M33.13M36.72M43.05M28.08M33.83M
R&D % of Revenue3.37%-2.28%1.18%49.51%29.97%65.74%64.57%85.06%190.63%70.57%58.55%184.87%317.85%214.1%180.92%175.43%153.49%235.58%133.18%189.62%
Other Operating Expenses01000K1000K1000K1000K001000K814K-1000K01000K0001K001000K0
Operating Income-7.74M-4.79M-6.81M-36.47M-22.32M-27.34M-22.09M-27.79M-36.57M-19.61M-13.76M-50.1M-58.87M-54.63M-50.73M-50.93M-47.27M-62M-49.92M-42.86M
Operating Margin %-48.25%-29.78%-38.63%-222.22%-169.85%-180.85%-151.04%-186.55%-280.63%-98.34%-39.59%-288.19%-473.63%-333.05%-306.96%-269.65%-197.58%-339.25%-236.77%-240.19%
Operating Income Growth %65.32%82.49%69.17%-31.25%38.97%-39.42%-60.6%44.54%37.88%64.1%72.88%1.61%-24.53%11.88%-1.62%-18.83%-57.48%-155.12%-116.65%-68.75%
EBITDA-6.04M-3.63M-5.65M-35.32M-21.13M-25.74M-18.77M-26.6M-35.38M-17.91M-11.01M-48.4M-56.95M-52.04M-47.5M-48.7M-45.07M-60.32M-48.19M-41.09M
EBITDA Margin %-37.66%-22.59%-32.07%-215.18%-160.79%-170.24%-128.32%-178.55%-271.49%-89.77%-31.67%-278.41%-458.23%-317.25%-287.4%-257.88%-188.4%-330.05%-228.54%-230.26%
EBITDA Growth %71.41%85.89%69.88%-32.79%40.28%-43.76%-70.56%45.05%37.89%65.6%76.83%0.62%-26.36%13.72%1.42%-18.54%-58.63%-163.03%-122.01%-70.73%
D&A (Non-Cash Add-back)1.7M1.16M1.16M1.16M1.19M1.6M3.32M1.19M1.19M1.71M2.75M1.7M1.91M2.59M3.23M2.22M2.2M1.68M1.74M1.77M
EBIT-7.74M-4.5M11.27M-9.58M-22.18M-23.39M-24.39M-27.33M-37.03M-27.09M-8.71M-54.1M-51.83M-52.25M-50.22M-51.33M-47.13M-62.12M-42.14M-22.23M
Net Interest Income-2.8M-1.07M-1.68M-1.45M-2.02M-2.07M-5.62M-1.39M-1.77M-1.35M-1.99M-2.91M-3.26M-4.06M-2.97M-3M-2.21M-5.77M-4.31M-2.61M
Interest Income570K637K736K622K490K526K589K734K833K707K547K715K1.04M687K419K150K142K144K132K146K
Interest Expense3.37M1.71M2.42M2.07M2.51M2.59M6.21M2.12M2.6M2.06M2.53M3.63M4.3M4.75M3.39M3.15M2.35M5.92M4.44M2.76M
Other Income/Expense150.03M-1.42M15.66M24.82M-2.37M1.37M-4.53M-1.04M-2.46M-8.99M3.17M-9.2M3.72M-2.36M-2.33M-3M-2.21M-6.03M4.06M18.47M
Pretax Income142.29M-6.21M8.85M-11.65M-24.69M-25.98M-26.63M-28.82M-39.02M-28.61M-10.58M-59.3M-55.15M-57M-53.06M-53.93M-49.48M-68.03M-45.86M-24.39M
Pretax Margin %887.23%-38.64%50.21%-71%-187.92%-171.82%-182%-193.5%-299.49%-143.41%-30.45%-341.08%-443.68%-347.45%-321.03%-285.56%-206.8%-372.26%-217.51%-136.7%
Income Tax5.13M-816K26K00336K69K00379K141K00449K000473K00
Effective Tax Rate %3.61%13.13%0.29%0%0%-1.29%-0.26%0%0%-1.32%-1.33%0%0%-0.79%0%0%0%-0.7%0%0%
Net Income110.37M-3.94M5.85M15.49M-10.58M-6.76M-12.87M-10.95M-15.42M-9.28M-5.04M-24.78M-21.54M-26.95M-22.51M-21.36M-15.76M-31.57M-20.78M-3.54M
Net Margin %688.2%-24.49%33.18%94.35%-80.55%-44.74%-87.96%-73.5%-118.32%-46.52%-14.52%-142.51%-173.28%-164.28%-136.2%-113.08%-65.87%-172.71%-98.56%-19.81%
Net Income Growth %1142.83%41.8%145.47%241.45%31.35%27.09%-155.04%55.81%28.42%65.57%77.59%-16.01%-36.66%14.63%-8.32%-504.13%-78.64%-496.13%-33.67%73.45%
Net Income (Continuing)137.16M-5.4M8.83M-11.65M-24.69M-26.32M-26.69M-28.82M-39.02M-28.98M-10.72M-59.3M-55.15M-57.45M-53.06M-53.93M-49.48M-68.51M-45.86M-24.39M
Discontinued Operations00000000000000000000
Minority Interest40.17M12.31M9.32M-6.54M10.24M-24.38M-33.9M-32.48M-26.96M-20.96M-29.92M-34.45M-17.99M8.3M39.68M70.48M95.72M117.2M119.81M140.02M
EPS (Diluted)2.82-0.200.110.45-0.48-0.37-0.76-0.73-1.03-1.19-0.94-3.65-3.47-7.80-4.11-3.90-2.70-5.66-3.83-0.65
EPS Growth %687.5%45.95%114.47%161.64%53.4%68.91%19.15%80%70.32%84.74%77.13%6.41%-28.52%-37.81%-7.31%-500%-64.63%-466%-25.16%77.66%
EPS (Basic)3.44-0.220.130.50-0.48-0.37-0.76-0.73-1.03-1.19-0.94-3.65-3.47-7.80-4.11-3.90-2.70-5.66-3.83-0.65
Diluted Shares Outstanding38.41M279.02M33.1M29.82M26.45M20.24M19.7M18.32M17.15M7.8M7.5M7.38M6.79M6.04M5.96M5.92M5.76M5.58M5.42M5.4M
Basic Shares Outstanding31.54M27.9M27.24M26.88M26.45M20.24M19.7M18.32M17.15M7.8M7.5M7.38M6.79M5.62M5.96M5.92M5.75M5.58M5.42M5.4M
Dividend Payout Ratio--2.84%1.07%----------------